Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome

This publication has 35 references indexed in Scilit:

• Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer
  The British Journal of Radiology, 2004
• Cisplatin-based combined modality therapy for anal carcinoma
  Cancer, 2003
• Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies
  Gynecologic Oncology, 2001
• Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
  The Lancet, 1996
• Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An eastern cooperative oncology group study
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Treatment planning at the University of North Carolina at Chapel Hill
  Seminars in Radiation Oncology, 1992
• Definitive Irradiation and Chemotherapy for Radiosensitization in Management of Anal Carcinoma: Interim Report on Radiation Therapy Oncology Group Study No. 8314
  JNCI Journal of the National Cancer Institute, 1989
• Combined therapy for cancer of the anal canal
  Diseases of the Colon & Rectum, 1981
• Combined treatment of squamous cell carcinoma of the anal canal
  Diseases of the Colon & Rectum, 1980